Abstract
Globally, many people have been affected with atopic dermatitis (AD), a chronic inflammatory skin disease. AD is associated with multiple factors such as genetic, inflammatory, and immune factors. Bee venom (BV) is now widely used for the treatment of several inflammatory diseases. However, its effect on 5% phthalic anhydride (PA)-induced AD has not been reported yet. We investigated the anti-inflammatory and anti-AD effects of BV in a PA-induced animal model of AD. Balb/c mice were treated with topical application of 5% PA to the dorsal skin and ears for induction of AD. After 24 h, BV was applied on the back and ear skin of the mice three times a week for 4 weeks. BV treatment significantly reduced the PA-induced AD clinical score, back and ear epidermal thickness, as well as IgE level and infiltration of immune cells in the skin tissues compared to those of control mice. The levels of inflammatory cytokines in the serum were significantly decreased in BV-treated group compared to PA-treated group. In addition, BV inhibited the expression of iNOS and COX-2 as well as the activation of mitogen-activated protein kinase (MAPK) and NF-ҡB induced by PA in the skin tissues. We also found that BV abrogated the lipopolysaccharide or TNF-α/IFN-γ-induced NO production, expression of iNOS and COX-2, as well as MAPK and NF-ҡB signaling pathway in RAW 264.7 and HaCaT cells. These results suggest that BV may be a potential therapeutic macromolecule for the treatment of AD.
Similar content being viewed by others
References
Ahn S, Siddiqi MH, Aceituno VC et al (2016) Ginsenoside Rg5:Rk1 attenuates TNF-alpha/IFN-gamma-induced production of thymus- and activation-regulated chemokine (TARC/CCL17) and LPS-induced NO production via downregulation of NF-kappaB/p38 MAPK/STAT1 signaling in human keratinocytes and macrophages. Vitro Cell Dev Biol Anim 52:287–295
Ban M, Hettich D (2005) Effect of Th2 cytokine antagonist treatments on chemical-induced allergic response in mice. J Appl Toxicol 25:239–247
Brandt EB, Sivaprasad U (2011) Th2 cytokines and atopic dermatitis. J Clin Cell Immunol 2:2011
Brunner PM, Guttman-Yassky E, Leung DY (2017) The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. J Allergy Clin Immunol 139:S65–S76
Chen L, Martinez O, Overbergh L, Mathieu C, Prabhakar BS, Chan LS (2004) Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin Exp Immunol 138:375–387
Choi YY, Kim MH, Lee H, Jo SY, Yang WM (2018) (R)-(+)-pulegone suppresses allergic and inflammation responses on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice model. J Dermatol Sci 91:292–300
Cohen DE, Heidary N (2004) Treatment of irritant and allergic contact dermatitis. Dermatol Ther 17:334–340
Dearman RJ, Kimber I (1992) Divergent immune responses to respiratory and contact chemical allergens: antibody elicited by phthalic anhydride and oxazolone. Clin Exp Allergy 22:241–250
Friedmann PS (2006) Contact sensitisation and allergic contact dermatitis: immunobiological mechanisms. Toxicol Lett 162:49–54
Han JH, Ju JH, Lee YS et al (2018) Astaxanthin alleviated ethanol-induced liver injury by inhibition of oxidative stress and inflammatory responses via blocking of STAT3 activity. Sci Rep 8:14090
Hartmann A, Mullner J, Meier N et al (2016) Bee venom for the treatment of Parkinson disease—a randomized controlled clinical trial. PLoS ONE 11:e0158235
Homey B, Steinhoff M, Ruzicka T, Leung DY (2006) Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 118:178–189
Jeon YD, Kee JY, Kim DS et al (2015) Effects of Ixeris dentata water extract and caffeic acid on allergic inflammation in vivo and in vitro. BMC Complement Altern Med 15:196
Ju Ho P, Jun Sung J, Ki Cheon K, Jin Tae H (2018) Anti-inflammatory effect of Centella asiatica phytosome in a mouse model of phthalic anhydride-induced atopic dermatitis. Phytomedicine 43:110–119
Jung M, Choi J, Lee SA, Kim H, Hwang J, Choi EH (2014) Pyrrolidone carboxylic acid levels or caspase-14 expression in the corneocytes of lesional skin correlates with clinical severity, skin barrier function and lesional inflammation in atopic dermatitis. J Dermatol Sci 76:231–239
Kim SY, Sohn EJ, Kim DW et al (2011) Transduced PEP-1-FK506BP ameliorates atopic dermatitis in NC/Nga mice. J Invest Dermatol 131:1477–1485
Kim IS, Kim MJ, Shin DH, Son KH, Park HY, Lee JS (2013a) Arazyme inhibits cytokine expression and upregulates skin barrier protein expression. Mol Med Rep 8:551–556
Kim KH, Lee WR, An HJ et al (2013b) Bee venom ameliorates compound 48/80-induced atopic dermatitis-related symptoms. Int J Clin Exp Pathol 6:2896–2903
Kim GD, Lee SE, Park YS, Shin DH, Park GG, Park CS (2014) Immunosuppressive effects of fisetin against dinitrofluorobenzene-induced atopic dermatitis-like symptoms in NC/Nga mice. Food Chem Toxicol 66:341–349
Lee JD, Kim SY, Kim TW et al (2004) Anti-inflammatory effect of bee venom on type II collagen-induced arthritis. Am J Chin Med 32:361–367
Lee YJ, Kim JE, Kwak MH et al (2014) Quantitative evaluation of the therapeutic effect of fermented soybean products containing a high concentration of GABA on phthalic anhydride-induced atopic dermatitis in IL-4/Luc/CNS-1 Tg mice. Int J Mol Med 33:1185–1194
Lee HJ, Kim MH, Choi YY et al (2016) Improvement of atopic dermatitis with topical application of Spirodela polyrhiza. J Ethnopharmacol 180:12–17
Lee DY, Hwang CJ, Choi JY et al (2017) Inhibitory effect of carnosol on phthalic anhydride-induced atopic dermatitis via inhibition of STAT3. Biomol Ther (Seoul) 25:535–544
Lee YS, Lee CH, Bae JT et al (2018) Inhibition of skin carcinogenesis by suppression of NF-κB dependent ITGAV and TIMP-1 expression in IL-32γ overexpressed condition. J Exp Clin Cancer Res 37:293
Leung DY (2000) Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 105:860–876
Li C, Maillet I, Mackowiak C et al (2017) Experimental atopic dermatitis depends on IL-33R signaling via MyD88 in dendritic cells. Cell Death Dis 8:e2735
Lim JM, Lee B, Min JH et al (2018) Effect of peiminine on DNCB-induced atopic dermatitis by inhibiting inflammatory cytokine expression in vivo and in vitro. Int Immunopharmacol 56:135–142
Man G, Hu LZ, Elias PM, Man MQ (2018) Therapeutic benefits of natural ingredients for atopic dermatitis. Chin J Integr Med 24:308–314
Neis MM, Peters B, Dreuw A et al (2006) Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol 118:930–937
Ozturk AB, Bayraktar R, Gogebakan B, Mumbuc S, Bayram H (2017) Comparison of inflammatory cytokine release from nasal epithelial cells of non-atopic non-rhinitic, allergic rhinitic and polyp subjects and effects of diesel exhaust particles in vitro. Allergol Immunopathol (Madr) 45:473–481
Park SJ, Lee YH, Lee KH, Kim TJ (2013) Effect of eriodictyol on the development of atopic dermatitis-like lesions in ICR mice. Biol Pharm Bull 36:1375–1379
Park JH, Kim MS, Jeong GS, Yoon J (2015) Xanthii fructus extract inhibits TNF-alpha/IFN-gamma-induced Th2-chemokines production via blockade of NF-kappaB, STAT1 and p38-MAPK activation in human epidermal keratinocytes. J Ethnopharmacol 171:85–93
Schakel K, Dobel T, Bosselmann I (2014) Future treatment options for atopic dermatitis—small molecules and beyond. J Dermatol Sci 73:91–100
Schreiber S, Kilgus O, Payer E et al (1992) Cytokine pattern of Langerhans cells isolated from murine epidermal cell cultures. J Immunol 149:3524–3534
Seo WY, Youn GS, Choi SY, Park J (2015) Butein, a tetrahydroxychalcone, suppresses pro-inflammatory responses in HaCaT keratinocytes. BMB Rep 48:495–500
Sredni-Kenigsbuch D, Shohat M, Shohat B, Ben-Amitai D, Chan CC, David M (2008) The novel tellurium immunomodulator AS101 inhibits interleukin-10 production and p38 MAPK expression in atopic dermatitis. J Dermatol Sci 50:232–235
Suh SJ, Kim KS, Kim MJ et al (2006) Effects of bee venom on protease activities and free radical damages in synovial fluid from type II collagen-induced rheumatoid arthritis rats. Toxicol In Vitro 20:1465–1471
Sun M, Wang S, Zhao L et al (2014) Suppression of 2,4-dinitrochlorobenzene-induced atopic dermatitis by extract of Bacillus Calmette–Guerin. Mol Med Rep 9:689–694
Sur B, Lee B, Yeom M et al (2016) Bee venom acupuncture alleviates trimellitic anhydride-induced atopic dermatitis-like skin lesions in mice. BMC Complement Altern Med 16:38
Suzuki H, Makino Y, Nagata M et al (2016) A rare variant in CYP27A1 and its association with atopic dermatitis with high serum total IgE. Allergy 71:1486–1489
Tan HY, Zhang AL, Chen D, Xue CC, Lenon GB (2013) Chinese herbal medicine for atopic dermatitis: a systematic review. J Am Acad Dermatol 69:295–304
Tanaka A, Konno M, Muto S et al (2005) A novel NF-kappaB inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors. Blood 105:2324–2331
Tanaka A, Muto S, Jung K, Itai A, Matsuda H (2007) Topical application with a new NF-kappaB inhibitor improves atopic dermatitis in NC/NgaTnd mice. J Invest Dermatol 127:855–863
Tokura Y (2010) Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci 58:1–7
Wullaert A, Bonnet MC, Pasparakis M (2011) NF-kappaB in the regulation of epithelial homeostasis and inflammation. Cell Res 21:146–158
Yamashita H, Tanaka H, Inagaki N (2013) Treatment of the chronic itch of atopic dermatitis using standard drugs and kampo medicines. Biol Pharm Bull 36:1253–1257
Yanashima K, Chieosilapatham P, Yoshimoto E, Okumura K, Ogawa H, Niyonsaba F (2017) Innate defense regulator IDR-1018 activates human mast cells through G protein-, phospholipase C-, MAPK- and NF-kB-sensitive pathways. Immunol Res 65:920–931
Yang G, Choi CH, Lee K, Lee M, Ham I, Choi HY (2013) Effects of Catalpa ovata stem bark on atopic dermatitis-like skin lesions in NC/Nga mice. J Ethnopharmacol 145:416–423
Zhang S, Liu Y, Ye Y et al (2018) Bee venom therapy: potential mechanisms and therapeutic applications. Toxicon 148:64–73
Acknowledgements
This work is financially supported by the National Research Foundation of Korea [NRF] Grant funded by the Korea Government (MSIP) (Grant number MRC2017R1A5A2015541). We would like to thank Editage (www.editage.co.kr) for English language editing.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that there is no duality of interest associated with this manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lee, Y.J., Oh, M.J., Lee, D.H. et al. Anti-inflammatory effect of bee venom in phthalic anhydride-induced atopic dermatitis animal model. Inflammopharmacol 28, 253–263 (2020). https://doi.org/10.1007/s10787-019-00646-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-019-00646-w